Publications by authors named "Kayo Asada"

Claim this Profile
I
Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.
Akira Nishijima, Katsutoshi Oda, Kosei Hasegawa, Takahiro Koso, Kayo Asada

Sci Rep· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of biopsy by office hysteroscopy for endometrial cancer: A case report.
Kenbun Sone, Satoko Eguchi, Kayo Asada, Futaba Inoue, Yuichiro Miyamoto

Mol Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma.
Hirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda, Shogo Yamamoto, Kayo Asada

J Immunother Cancer· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone methyltransferase SMYD2 selective inhibitor LLY-507 in combination with poly ADP ribose polymerase inhibitor has therapeutic potential against high-grade serous ovarian carcinomas.
Asako Kukita, Kenbun Sone, Katsutoshi Oda, Ryuji Hamamoto, Syuzo Kaneko, Kayo Asada

Biochem Biophys Res Commun· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
Machiko Kojima, Kenbun Sone, Katsutoshi Oda, Ryuji Hamamoto, Syuzo Kaneko, Kayo Asada

BMC Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The frequency of neoantigens per somatic mutation rather than overall mutational load or number of predicted neoantigens per se is a prognostic factor in ovarian clear cell carcinoma.
Hirokazu Matsushita, Kosei Hasegawa, Katsutoshi Oda, Shogo Yamamoto, Akira Nishijima, Kayo Asada

Oncoimmunology· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 is a potential therapeutic target and prognostic factor for ovarian clear cell carcinomas with wild type TP53.
Chinami Makii, Katsutoshi Oda, Yuji Ikeda, Kenbun Sone, Kosei Hasegawa, Kayo Asada

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of TP53 and PI3K signaling pathways as molecular targets in gynecologic malignancies.
Katsutoshi Oda, Yuji Ikeda, Tomoko Kashiyama, Aki Miyasaka, Kanako Inaba, Kayo Asada

J Obstet Gynaecol Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
Yuriko Uehara, Katsutoshi Oda, Yuji Ikeda, Takahiro Koso, Shingo Tsuji, Kayo Asada

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Integrated Copy Number and Expression Analysis Identifies Profiles of Whole-Arm Chromosomal Alterations and Subgroups with Favorable Outcome in Ovarian Clear Cell Carcinomas.
Yuriko Uehara, Katsutoshi Oda, Yuji Ikeda, Takahiro Koso, Shingo Tsuji, Kayo Asada

PLoS One· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor prognosis of ovarian cancer with large cell neuroendocrine carcinoma: case report and review of published works.
Kayo Asada, Kei Kawana, Shinichi Teshima, Ako Saito, Masakiyo Kawabata

J Obstet Gynaecol Res· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laparoscopic ovarian-sparing surgery for a young woman with an exophytic ovarian fibroma.
Akiko Hasegawa, Kaori Koga, Kayo Asada, Osamu Wada-Hiraike, Yutaka Osuga

J Obstet Gynaecol Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis